Sun Pharmaceutical Industries Ltd To Buy Struggling Ranbaxy Laboratories In $3.2-Billion Landmark Transaction

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TOKYO/MUMBAI, April 7 (Reuters) - India's Sun Pharmaceutical Industries Ltd has agreed to buy generic drugmaker Ranbaxy Laboratories Ltd for $3.2 billion, betting it can fix factory quality glitches that plagued the current owner, Japan's Daiichi Sankyo Co, and got Ranbaxy India-made drugs barred from the United States.

Help employers find you! Check out all the jobs and post your resume.

Back to news